Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$557,959,289
+$145,765,737 QoQ
Shares Held
465,187
+21.3% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
6.01%
of 13F equity value
Holder Rank
#133
of 4,627 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Jun 30, 2025CallValue
$1,598,971,936
CallShares
2,051,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Castle Hook Partners LP holds $557,959,289 across 1 Drug Manufacturers - General name. LLY ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
465,187 | $557,959,289 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $557,959,289 | 465,187 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $412,193,552 | 383,550 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $304,482,017 | 399,059 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $82,201,438 | 105,450 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $1,598,971,936 | 2,051,200 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $260,415,204 | 315,307 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $69,731,672 | 90,326 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||